multihance injection 15 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
multihance injection 20 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
technescan dtpa for injection 20.8 mgvial
qt instruments (s) pte ltd - pentetic acid - injection, powder, for solution - 25 mg/vial - pentetic acid 20.8 mg/vial
dotarem gadoteric acid 279.32mg/ml injection 20 ml pre-filled syringe
guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 15 ml pre-filled syringe
guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 10 ml pre-filled syringe
guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 5ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 10ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: water for injections; meglumine - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 15ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).
dotarem gadoteric acid 279.32mg/ml injection 20ml vial
guerbet australia pty ltd - gadoteric acid, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use in magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).